Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Unlike many clinics that charge separate consult fees or push bundled memberships, Amble keeps it simple
Kamel H, Okin PM, Elkind MSV, et al
10.1016/j.tox.2024.153799 518 ZhouJ.TangM.LiW.FangR.TangC.WangQ
The legal status depends on the country and its regulations
Combined Targeting of E-selectin/CXCR4 and FLT3 by GMI-1359 and Sorafenib Effectively Reduces Leukemia Cell Burden and Protects Normal Hematopoiesis in a Patient-derived AML Xenograft Model
US$ 21.47
US$ 29.12
US$ 25.38
US$ 21.25
US$ 26.64
US$ 24.74
US$ 27.34
